189 related articles for article (PubMed ID: 17911601)
1. Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin.
Ruppelt A; Mosenden R; Grönholm M; Aandahl EM; Tobin D; Carlson CR; Abrahamsen H; Herberg FW; Carpén O; Taskén K
J Immunol; 2007 Oct; 179(8):5159-68. PubMed ID: 17911601
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal control of cyclic AMP immunomodulation through the PKA-Csk inhibitory pathway is achieved by anchoring to an Ezrin-EBP50-PAG scaffold in effector T cells.
Cornez I; Taskén K
FEBS Lett; 2010 Jun; 584(12):2681-8. PubMed ID: 20420835
[TBL] [Abstract][Full Text] [Related]
3. Targeting of type I protein kinase A to lipid rafts is required for platelet inhibition by the 3',5'-cyclic adenosine monophosphate-signaling pathway.
Raslan Z; Magwenzi S; Aburima A; Taskén K; Naseem KM
J Thromb Haemost; 2015 Sep; 13(9):1721-34. PubMed ID: 26176741
[TBL] [Abstract][Full Text] [Related]
4. The adaptor protein EBP50 is important for localization of the protein kinase A-Ezrin complex in T-cells and the immunomodulating effect of cAMP.
Stokka AJ; Mosenden R; Ruppelt A; Lygren B; Taskén K
Biochem J; 2009 Dec; 425(2):381-8. PubMed ID: 19857202
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP-mediated immune regulation--overview of mechanisms of action in T cells.
Mosenden R; Taskén K
Cell Signal; 2011 Jun; 23(6):1009-16. PubMed ID: 21130867
[TBL] [Abstract][Full Text] [Related]
6. Dual specificity A-kinase anchoring proteins (AKAPs) contain an additional binding region that enhances targeting of protein kinase A type I.
Jarnaess E; Ruppelt A; Stokka AJ; Lygren B; Scott JD; Taskén K
J Biol Chem; 2008 Nov; 283(48):33708-18. PubMed ID: 18824551
[TBL] [Abstract][Full Text] [Related]
7. The molecular machinery for cAMP-dependent immunomodulation in T-cells.
Taskén K; Stokka AJ
Biochem Soc Trans; 2006 Aug; 34(Pt 4):476-9. PubMed ID: 16856837
[TBL] [Abstract][Full Text] [Related]
8. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor.
Vang T; Torgersen KM; Sundvold V; Saxena M; Levy FO; Skålhegg BS; Hansson V; Mustelin T; Taskén K
J Exp Med; 2001 Feb; 193(4):497-507. PubMed ID: 11181701
[TBL] [Abstract][Full Text] [Related]
9. AKAPs in lipid rafts are required for optimal antigen presentation by dendritic cells.
Schillace RV; Miller CL; Carr DW
Immunol Cell Biol; 2011 Jul; 89(5):650-8. PubMed ID: 21221125
[TBL] [Abstract][Full Text] [Related]
10. Mice with disrupted type I protein kinase A anchoring in T cells resist retrovirus-induced immunodeficiency.
Mosenden R; Singh P; Cornez I; Heglind M; Ruppelt A; Moutschen M; Enerbäck S; Rahmouni S; Taskén K
J Immunol; 2011 May; 186(9):5119-30. PubMed ID: 21430226
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly.
Itoh K; Sakakibara M; Yamasaki S; Takeuchi A; Arase H; Miyazaki M; Nakajima N; Okada M; Saito T
J Immunol; 2002 Jan; 168(2):541-4. PubMed ID: 11777944
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of T-cell receptor activation by the cAMP-PKA-Csk signalling pathway in T-cell lipid rafts.
Tasken K; Ruppelt A
Front Biosci; 2006 Sep; 11():2929-39. PubMed ID: 16720365
[TBL] [Abstract][Full Text] [Related]
13. Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.
Rahmouni S; Vang T; Alonso A; Williams S; van Stipdonk M; Soncini C; Moutschen M; Schoenberger SP; Mustelin T
Mol Cell Biol; 2005 Mar; 25(6):2227-41. PubMed ID: 15743820
[TBL] [Abstract][Full Text] [Related]
14. Modulation of T cell immune functions by the prostaglandin E(2) - cAMP pathway in chronic inflammatory states.
Brudvik KW; Taskén K
Br J Pharmacol; 2012 May; 166(2):411-9. PubMed ID: 22141738
[TBL] [Abstract][Full Text] [Related]
15. A displaced PAG enhances proximal signaling and SDF-1-induced T cell migration.
Posevitz-Fejfár A; Smída M; Kliche S; Hartig R; Schraven B; Lindquist JA
Eur J Immunol; 2008 Jan; 38(1):250-9. PubMed ID: 18085663
[TBL] [Abstract][Full Text] [Related]
16. Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A.
Staples KJ; Bergmann M; Tomita K; Houslay MD; McPhee I; Barnes PJ; Giembycz MA; Newton R
J Immunol; 2001 Aug; 167(4):2074-80. PubMed ID: 11489990
[TBL] [Abstract][Full Text] [Related]
17. Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton.
Brdicková N; Brdicka T; Andera L; Spicka J; Angelisová P; Milgram SL; Horejsí V
FEBS Lett; 2001 Oct; 507(2):133-6. PubMed ID: 11684085
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Kv1.3 channels by protein kinase A I in T lymphocytes is mediated by the disc large 1-tyrosine kinase Lck complex.
Kuras Z; Kucher V; Gordon SM; Neumeier L; Chimote AA; Filipovich AH; Conforti L
Am J Physiol Cell Physiol; 2012 May; 302(10):C1504-12. PubMed ID: 22378744
[TBL] [Abstract][Full Text] [Related]
19. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling.
Vang T; Abrahamsen H; Myklebust S; Horejsí V; Taskén K
J Biol Chem; 2003 May; 278(20):17597-600. PubMed ID: 12665526
[TBL] [Abstract][Full Text] [Related]
20. PKA-type I selective constrained peptide disruptors of AKAP complexes.
Wang Y; Ho TG; Franz E; Hermann JS; Smith FD; Hehnly H; Esseltine JL; Hanold LE; Murph MM; Bertinetti D; Scott JD; Herberg FW; Kennedy EJ
ACS Chem Biol; 2015 Jun; 10(6):1502-10. PubMed ID: 25765284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
